BlackRock »

Ligand Pharmaceuticals In shares owned by BlackRock

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $300M 3.0M 100.09

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Ashford Capital Management
Rice Hall James & Associates
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In